Microchip-Based Structure Determination of Disease-Relevant p53

Maria J Solares1,2,3, G M Jonaid4,2,3, William Y Luqiu3,5

  • 1Molecular, Cellular, and Integrative Biosciences Graduate Program, Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, United States.

Analytical Chemistry
|October 30, 2020
PubMed

Insights

Researchers developed a microchip technology to study the tumor suppressor protein TP53 (p53) structure. This method reveals new details about p53 assemblies and ubiquitination sites, crucial for understanding cancer progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nanotechnology

Background:

  • The tumor suppressor protein TP53 (p53) is vital in human cells, and its mutations are linked to cancer.
  • Incomplete structural information for p53 hinders a full understanding of its function and role in disease.
  • Existing methods for p53 structural analysis face limitations.

Purpose of the Study:

  • To present a novel microchip-based technology for studying p53 assemblies.
  • To obtain high-resolution structural data of p53 from human cancer cells.
  • To investigate the structural basis of p53's role in cancer.

Main Methods:

  • Development of a microchip device for p53 structural studies without altering the native gene sequence or post-translational modifications.
  • Application of cryo-electron microscopy (cryo-EM) for structural determination.
  • Analysis of p53 monomer and tetramer structures.

Main Results:

  • Cryo-EM resolved structures of the p53 monomer at ~4.8 Å and tetramer at ~7 Å.
  • The structures provided insights into flexible regions of p53.
  • Biologically relevant ubiquitination sites on p53 were identified.

Conclusions:

  • The microchip technology offers a new platform for p53 structural studies.
  • The resolved structures enhance understanding of p53's molecular mechanisms.
  • This approach provides a framework for investigating the oncogenic impact of p53.